News

Latest news

Hide mandatory notifications of trade

Subsequent Offering

17.03.2010 - Reference is made to stock exchange notice dated 8 March 2010, the prospectus dated 18 February 2010 regarding the subsequent offering of up to 10,000,000 Subsequent Offering Shares in Nutri Pharma ASA ("Nutri Pharma") to a price of NOK 2.00 per share

This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)

Reference is made to stock exchange notice dated 8 March 2010, the  prospectus
dated  18 February 2010 regarding the subsequent offering of up to 10,000,000
Subsequent Offering Shares in Nutri Pharma ASA ("Nutri Pharma") to a price of
NOK 2.00 per share, constituting gross proceeds of up to NOK 20,000,000 (the
"Subsequent Offering").

The following company resolution has today been registered in the Norwegian
Register of Business Enterprises:

·        Capital increase of NOK 24,114.25 by issuance of 100,457 new shares
settled in cash by NOK 200,914 (completion of the Subsequent Offering) on the
basis of registered authorization to the board of directors approved in the
extraordinary shareholders meeting in Nutri Pharma on 12 February 2010.

Following the registration above, the new share capital of the Company is NOK
45,131,587 divided into 180,526,348 shares.

Oslo, 17 March 2010

For further information, please contact:
Trond Syvertsen, CEO  + 47 23 01 09 60 / + 47 91 72 14 57

 

[HUG#1395027]